Finance

Lists
Why is 000227 up 3.23%?
Dive Deeper
000227:KRX
Yuyu Pharma Pref Shs
₩7,990.00
+3.23%
(+250.00) 1D
Oct 19, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000227...
Open
₩8,000
High
₩8,000
Low
₩7,720
Mkt. cap
70.90B
Avg. vol.
1.25K
Volume
208.00
Dividend
1.44%
Quarterly dividend
₩29
Ex-dividend date
Dec 27, 2024
P/E ratio
11.93
52-wk high
₩12,400
52-wk low
₩5,810
EPS
₩669
Shares outstanding
322.96K
No. of employees
243
Open
₩8,000
High
₩8,000
Low
₩7,720
Mkt. cap
70.90B
Avg. vol.
1.25K
Volume
208.00
Dividend
1.44%
Quarterly dividend
₩29
Ex-dividend date
Dec 27, 2024
P/E ratio
11.93
52-wk high
₩12,400
52-wk low
₩5,810
EPS
₩669
Shares outstanding
322.96K
No. of employees
243
News stories
From web sources and news partners
About Yuyu Pharma Pref Shs
CEO-
Employees243
Founded1941
Headquarters-
SectorPharmaceutical industry
Websiteyuyu.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
37.79B
34.34B
35.54B
36.70B
Cost of goods sold
23.00B
22.54B
21.04B
22.11B
Cost of revenue
23.00B
22.54B
21.04B
22.11B
Research and development expenses
914.90M
1.15B
703.42M
781.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.71B
10.17B
8.95B
9.33B
Operating expense
9.81B
11.93B
10.19B
10.59B
Total operating expenses
32.81B
34.47B
31.24B
32.69B
Operating income
4.99B
-129.07M
4.30B
4.00B
Other non operating income
56.65M
-1.13B
863.61M
-184.40M
EBT including unusual items
4.82B
202.03M
3.97B
4.13B
EBT excluding unusual items
4.77B
-1.11B
4.99B
3.68B
Income tax expense
504.29M
-1.00B
620.45M
574.52M
Effective tax rate
10.46%
-496.97%
15.62%
13.91%
Other operating expenses
18.27M
76.24M
40.94M
36.86M
Net income
3.98B
1.39B
3.49B
3.65B
Net profit margin
10.52%
4.03%
9.82%
9.95%
Earnings per share
-
-
-
-
Interest and investment income
136.07M
529.96M
286.44M
226.76M
Interest expense
-540.35M
-547.07M
-474.32M
-436.45M
Net interest expenses
-404.28M
-17.11M
-187.88M
-209.69M
Depreciation and amortization charges
320.96M
403.34M
334.87M
409.27M
EBITDA
6.34B
1.33B
5.68B
5.46B
Gain or loss from assets sale
-13.34M
-
-499.00K
-3.19M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps